| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
GUTS
Fractyl Health, Inc.
|
Aug 10, 2026 | BUY |
Strong Buy
+557.2% avg upside
7 analysts
|
$2.00
184.90% Upside
|
· | · |
|
AXSM
Axsome Therapeutics
|
Aug 10, 2026 | BUY |
Strong Buy
+8.8% avg upside
29 analysts
|
$276.00
27.84% Upside
|
-2.8% | · |
|
JAZZ
Jazz Pharmaceuticals
|
Aug 10, 2026 | BUY |
Strong Buy
-5.0% avg upside
35 analysts
|
$307.00
23.89% Upside
|
-2.0% | · |
|
AMPH
Amphastar Pharmaceuticals
|
Aug 07, 2026 | SELL |
Hold
+25.7% avg upside
11 analysts
|
$20.00
1.99% Downside
|
+1.5% | · |
|
OCS
Oculis Holding
|
Aug 07, 2026 | BUY |
Strong Buy
+196.4% avg upside
11 analysts
|
$32.00
150.96% Upside
|
+1.7% | · |
|
XENE
Xenon
|
Aug 07, 2026 | BUY |
Strong Buy
-1.9% avg upside
28 analysts
|
$77.00
21.89% Upside
|
+2.3% | · |
|
EXEL
Exelixis
|
Aug 05, 2026 | SELL |
Buy
-15.5% avg upside
34 analysts
|
$41.00
20.14% Downside
|
+11.2% | · |
|
PCVX
Vaxcyte
|
Aug 05, 2026 | BUY |
Strong Buy
+75.9% avg upside
15 analysts
|
$133.00
124.64% Upside
|
+6.6% | · |
|
MRK
Merck & Company
|
Aug 05, 2026 | BUY |
Strong Buy
-0.7% avg upside
43 analysts
|
$141.00
8.13% Upside
|
+1.6% | · |
|
LLY
Eli Lilly & Co
|
Aug 05, 2026 | BUY |
Strong Buy
-13.8% avg upside
48 analysts
|
$1344.00
10.63% Upside
|
+4.3% | · |
|
PFE
Pfizer
|
Aug 04, 2026 | HOLD |
Buy
+25.8% avg upside
45 analysts
|
$27.00
1.42% Upside
|
+6.5% | · |
|
HRMY
Harmony Biosciences Holdings
|
Aug 04, 2026 | SELL |
Strong Buy
+23.1% avg upside
13 analysts
|
$30.00
24.03% Downside
|
-2.5% | · |
|
ARWR
Arrowhead Pharmaceuticals
|
Aug 04, 2026 | BUY |
Strong Buy
-15.9% avg upside
27 analysts
|
$100.00
11.97% Upside
|
-2.6% | · |
|
BMY
Bristol-Myers Squibb
|
Aug 03, 2026 | BUY |
Buy
-4.4% avg upside
42 analysts
|
$71.00
11.63% Upside
|
-1.0% | · |
|
ABBV
AbbVie
|
Jul 31, 2026 | BUY |
Strong Buy
-4.3% avg upside
46 analysts
|
$276.00
10.31% Upside
|
-0.9% | · |
|
TEVA
Teva Pharmaceutical
|
Jul 30, 2026 | BUY |
Buy
-17.3% avg upside
39 analysts
|
$41.00
12.37% Upside
|
+0.0% | · |
|
IONS
Ionis Pharmaceuticals
|
Jul 29, 2026 | BUY |
Strong Buy
+42.3% avg upside
43 analysts
|
$93.00
67.78% Upside
|
+5.4% | · |
|
JNJ
Johnson & Johnson
|
Jul 28, 2026 | HOLD |
Strong Buy
-9.2% avg upside
39 analysts
|
$263.00
1.16% Upside
|
-2.6% | · |
|
ALKS
Alkermes
|
Jul 28, 2026 | SELL |
Strong Buy
-15.7% avg upside
34 analysts
|
$38.00
22.84% Downside
|
+2.8% | · |
|
UTHR
United Therapeutics
|
Jul 10, 2026 | HOLD |
Buy
-16.7% avg upside
26 analysts
|
$613.00
18.87% Upside
|
-6.5% | · |
|
RPRX
Royalty Pharma
|
Jul 10, 2026 | BUY |
Strong Buy
+0.5% avg upside
15 analysts
|
— | +4.9% | · |
|
VTRS
Viatris
|
Jul 10, 2026 | SELL |
Buy
+44.1% avg upside
21 analysts
|
$14.00
13.97% Downside
|
+1.0% | · |
|
TARS
Tarsus Pharmaceuticals
|
Jul 08, 2026 | BUY |
Strong Buy
+12.7% avg upside
16 analysts
|
$89.00
28.05% Upside
|
-4.3% | · |
|
LQDA
Liquidia Technologies
|
Jun 29, 2026 | HOLD |
Strong Buy
-28.4% avg upside
15 analysts
|
$79.00
10.25% Downside
|
+4.9% | · |
|
BMRN
BioMarin Pharmaceutical
|
May 29, 2026 | BUY |
Strong Buy
+36.7% avg upside
52 analysts
|
$80.00
15.05% Upside
|
+22.6% | · |
|
IMVT
Immunovant
|
May 21, 2026 | BUY |
Strong Buy
-1.8% avg upside
24 analysts
|
$43.00
5.02% Upside
|
+24.8% | · |
|
LENZ
LENZ Therapeutics
|
May 12, 2026 | BUY |
Buy
+352.6% avg upside
17 analysts
|
$31.00
494.96% Upside
|
-36.3% | · |
|
MLYS
Mineralys Therapeutics, Inc.
|
May 07, 2026 | BUY |
Strong Buy
+64.8% avg upside
12 analysts
|
— | -7.8% | · |
|
AMLX
Amylyx Pharmaceuticals Inc
|
Apr 28, 2026 | BUY |
Strong Buy
+16.1% avg upside
14 analysts
|
$22.00
6.98% Downside
|
-6.8% | · |
|
TSE:BHC
Bausch Health Companies
|
Feb 18, 2026 | SELL |
Buy
+568.6% avg upside
29 analysts
|
$6.97
19.69% Downside
|
-2.2% | · |
|
OGN
Organon
|
Feb 13, 2026 | SELL |
Sell
+8.9% avg upside
9 analysts
|
— | -85.6% | · |
|
PROK
ProKidney
|
Jan 12, 2026 | SELL |
Buy
+309.0% avg upside
12 analysts
|
$1.00
37.83% Downside
|
+29.6% | · |
|
BHVN
Biohaven Ltd.
|
Nov 10, 2025 | HOLD |
Buy
+59.5% avg upside
25 analysts
|
$10.00
30.95% Downside
|
+86.7% | · |
|
NL:LKFT
Galapagos
|
Nov 07, 2025 | SELL |
Sell
+114.7% avg upside
16 analysts
|
— | +18.9% | · |
|
LKFT
Lakefront Biotherapeutics
|
Nov 06, 2025 | SELL |
Buy
+271.6% avg upside
24 analysts
|
$28.00
2.57% Downside
|
+13.5% | · |
|
RLAY
Relay Therapeutics
|
Nov 06, 2025 | BUY |
Strong Buy
+8.6% avg upside
21 analysts
|
$15.00
24.88% Downside
|
+207.4% | · |
|
LYRA
Lyra Therapeutics
|
May 23, 2024 | HOLD |
Hold
+8457.1% avg upside
7 analysts
|
— | · | · |
|
CHRS
Coherus Biosciences
|
Oct 30, 2023 | HOLD |
Buy
+923.6% avg upside
18 analysts
|
— | -75.1% | · |
|
ALLO
Allogene Therapeutics
|
Sep 28, 2023 | HOLD |
Strong Buy
+616.7% avg upside
28 analysts
|
— | -14.7% | · |
|
TVRD
Tvardi Therapeutics
|
Aug 09, 2023 | SELL |
Buy
+921.8% avg upside
23 analysts
|
$3.50
97.76% Upside
|
· | · |
|
KYNB
Kyntra Bio
|
Aug 08, 2023 | SELL |
Buy
+350.7% avg upside
15 analysts
|
$2.00
71.63% Downside
|
+69.4% | · |
|
BYSI
Beyondspring
|
Jan 05, 2023 | SELL |
Hold
+921.5% avg upside
8 analysts
|
$1.00
26.52% Upside
|
+49.7% | · |
|
FNCHQ
Finch Therapeutics Group
|
May 17, 2022 | BUY |
Strong Buy
+141.8% avg upside
3 analysts
|
$11.00
7.75% Upside
|
-85.7% | · |
|
VRCA
Verrica Pharmaceuticals
|
Jul 15, 2020 | HOLD |
Strong Buy
+250.2% avg upside
8 analysts
|
$10.00
91.48% Upside
|
+30.7% | · |
|
YARW
Yarrow Bioscience
|
Mar 11, 2020 | BUY |
Strong Buy
-35.4% avg upside
9 analysts
|
$32.00
25.41% Downside
|
· | · |
|
ALNY
Alnylam Pharma
|
Nov 13, 2019 | BUY |
Strong Buy
+46.8% avg upside
51 analysts
|
$110.00
50.36% Downside
|
+49.6% | · |
|
NBRVF
Nabriva Therapeutics
|
Aug 20, 2019 | BUY |
Buy
+13374900.0% avg upside
9 analysts
|
$6.00
5999899.93% Upside
|
· | · |
|
DE:MRK
Merck KGaA
|
Jun 28, 2019 | SELL |
Buy
-2.2% avg upside
33 analysts
|
— | -12.4% | · |
|
SPRO
Spero Therapeutics
|
Oct 16, 2018 | SELL |
Buy
+1014.9% avg upside
12 analysts
|
$9.00
631.68% Upside
|
-27.1% | · |
|
ARDX
Ardelyx
|
Nov 20, 2016 | BUY |
Strong Buy
+239.9% avg upside
21 analysts
|
$18.00
356.76% Upside
|
-63.6% | · |
|
HRTX
Heron Therapeutics
|
Nov 15, 2016 | BUY |
Strong Buy
+8713.8% avg upside
21 analysts
|
$34.00
10400.38% Upside
|
· | · |
|
PCRX
Pacira Pharmaceuticals
|
Nov 02, 2016 | HOLD |
Buy
+60.2% avg upside
21 analysts
|
$37.00
51.67% Upside
|
-0.9% | · |
|
PRGO
Perrigo Company
|
Aug 10, 2016 | HOLD |
Buy
+431.9% avg upside
20 analysts
|
$81.00
530.28% Upside
|
-10.0% | · |
|
AMRX
Amneal Pharmaceuticals
|
Aug 09, 2016 | HOLD |
Strong Buy
+3.6% avg upside
18 analysts
|
$24.00
40.32% Upside
|
· | · |
|
NVO
Novo Nordisk
|
Aug 08, 2016 | HOLD |
Buy
+145.4% avg upside
26 analysts
|
— | -10.1% | · |
|
IRWD
Ironwood Pharma
|
Aug 05, 2016 | HOLD |
Buy
+178.5% avg upside
23 analysts
|
$14.00
225.65% Upside
|
+15.6% | · |
|
NBIX
Neurocrine
|
Jul 13, 2016 | BUY |
Strong Buy
+15.6% avg upside
37 analysts
|
$70.00
56.80% Downside
|
+1.6% | · |
|
CARM
Carisma Therapeutics
|
Jan 19, 2016 | HOLD |
Buy
+116900.1% avg upside
11 analysts
|
— | · | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.